Table 3. CFQ-R Treatment Burden Scale Scores Differ Based on Treatment Activities.
| n | CFQ-R Treatment Burden Scalec Mean (SD) |
|
|---|---|---|
| Overall | 204 | 52.3 (22.1) |
| Gendera | ||
| Male | 77 | 56.5 (23.0) |
| Female | 127 | 49.9 (21.3) |
| Age (years) | ||
| 18-24 | 29 | 55.9 (17.6) |
| 25-34 | 70 | 53.4 (21.8) |
| 35-44 | 66 | 48.4 (20.7) |
| >45 | 38 | 55.1 (28.5) |
| FEV1 (% predicted) | ||
| <40% | 27 | 48.1 (20.2) |
| 40%-70% | 97 | 51.1 (20.4) |
| >70% | 55 | 55.2 (24.1) |
| # Nebulized Medicationsa | ||
| 0 | 46 | 64.3 (24.0) |
| 1 | 48 | 59.1 (16.0) |
| 2 | 46 | 43.9 (20.6) |
| ≥3 | 64 | 45.8 (20.7) |
| Performed ACTa | ||
| No | 62 | 62.8 (23.1) |
| Yes | 142 | 47.4 (20.0) |
| # Inhaled (MDI) Medicationsa | ||
| 0 | 38 | 60.6 (21.9) |
| 1 | 62 | 58.4 (20.2) |
| 2 | 70 | 47.0 (20.7) |
| ≥3 | 34 | 41.1 (21.6) |
| # MDI Times/Daya | ||
| 0 | 38 | 60.6 (21.9) |
| 1-2 | 65 | 58.0 (20.8) |
| 3-4 | 64 | 48.1 (20.2) |
| ≥5 | 38 | 39.7 (21.1) |
| # Oral Medicationsa,b | ||
| 0-1 | 70 | 59.7 (24.8) |
| 2-3 | 96 | 48.4 (19.3) |
| ≥4 | 38 | 46.7 (20.0) |
| # Oral Medication Times/Daya,b | ||
| 0 | 28 | 65.9 (25.1) |
| 1-2 | 62 | 53.8 (21.9) |
| 3-4 | 74 | 46.6 (17.6) |
| ≥5 | 41 | 48.8 (23.2) |
a
p< 0.05
b
For oral medications, pancreatic enzymes were excluded from analysis
c
CFQ-R Treatment Burden Scale is from 0-100, with a lower score representing a higher treatment burden